SEC Form 4 · accession 0000947871-17-000724
WebMD Health Corp. · WBMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Kristiina Vuori M.D.
Director
Period of report
Sep 15, 2017
Accepted (ET)
Sep 15, 2017 · 12:12 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001326583
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Sep 15, 2017 | U | 1,790 | $66.50 | D | 0 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F2 | $50.89 | Sep 15, 2017 | D | 13,200 | D | — | Jul 7, 2024 | Common Stock | 13,200 | 0 | D |
| Stock Option (right to buy)F2 | $39.55 | Sep 15, 2017 | D | 13,200 | D | — | Jan 1, 2025 | Common Stock | 13,200 | 0 | D |
| Stock Option (right to buy)F2 | $48.30 | Sep 15, 2017 | D | 13,200 | D | — | Jan 1, 2026 | Common Stock | 13,200 | 0 | D |
| Stock Option (right to buy)F2 | $49.57 | Sep 15, 2017 | D | 13,200 | D | — | Jan 1, 2027 | Common Stock | 13,200 | 0 | D |
Explanation of responses
- F1Sold in a tender offer made by Diagnosis Merger Sub, Inc., a Delaware Corporation ("Purchaser") and a wholly-owned subsidiary of MH Sub I, LLC, a Delaware limited liability company ("Parent"), to purchase all of the issued and outstanding shares of common stock of WebMD Health Corp., a Delaware corporation ("WebMD"), for $66.50 per share, pursuant to the terms of that certain Agreement and Plan of Merger, dated as of July 24, 2017, by and among WebMD, Purchaser, and Parent (the "Merger Agreement").
- F2On September 15, 2017, the merger transaction (the "Merger") contemplated by the Merger Agreement was completed and WebMD was acquired by the Purchaser and ceased to be a public company. Pursuant to the Merger Agreement, each option that was vested and exercisable immediately prior to completion of the Merger, or that vested upon completion of the Merger in accordance with its terms, was automatically cancelled in exchange for the right of the holder to receive an amount in cash equal to the excess of $66.50 over the exercise price of each such option. In connection with the completion of the Merger, each unvested option held by the Reporting Person fully accelerated. The Reporting Person no longer owns any securities issued by WebMD.